4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-21-042719
Chief Financial Officer bought 2,000 shares at $4.74 ($9,480)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Freve Jonathan Chief Financial Officer | 2021-06-23 | Purchase | +2,000 | $4.74 | $9,480 | 2,000 | D |
| Open-market purchases · 2,000 sh · avg $4.74 · $9,480 | |||||||
Loading xslF345X03/doc4.xml…